Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The company's AEM instruments product line includes a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also provides various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; and AEM Burn Protection Cable, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was founded in 1991 and is based in Boulder, Colorado.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone303-444-2600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$8.80 million
Profitability
Miscellaneous
Employees36
Next Earnings Date11/5/2019 (Estimated)
OptionableNot Optionable
Encision (OTCMKTS:ECIA) Frequently Asked Questions
What is Encision's stock symbol?
Encision trades on the OTCMKTS under the ticker symbol "ECIA."
How were Encision's earnings last quarter?
Encision, Inc. (OTCMKTS:ECIA) issued its earnings results on Monday, August, 12th. The medical device company reported ($0.02) EPS for the quarter. The medical device company had revenue of $1.93 million for the quarter. Encision had a negative return on equity of 18.76% and a negative net margin of 5.25%. View Encision's Earnings History.
When is Encision's next earnings date?
Has Encision been receiving favorable news coverage?
News stories about ECIA stock have trended negative on Tuesday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Encision earned a news sentiment score of -2.3 on InfoTrie's scale. They also assigned news headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Encision.
Who are some of Encision's key competitors?
Some companies that are related to Encision include Biostage (BSTG), Lianluo Smart (LLIT), Obalon Therapeutics (OBLN), Valeritas (VLRX), Dynatronics (DYNT), Avinger (AVGR), CELLECT BIOTECH/S (APOP), Invivo Therapeutics (NVIV), Presbia (LENS), Cytori Therapeutics (CYTX), Calmare Therapeutics (CTTC), United American Healthcare (UAHC), Neurometrix (NURO), Cytocore (MDIT) and Regenicin (RGIN).
What other stocks do shareholders of Encision own?
Who are Encision's key executives?
Encision's management team includes the folowing people:
- Mr. Gregory J. Trudel, CEO, Pres & Director (Age 58)
- Mr. David W. Newton, Co-Founder, VP of Technology & Director (Age 72)
- Mr. Peter Geary, VP of Operations (Age 61)
- Ms. Mala Ray, VP, Controller, Treasurer, Sec., Principal Accounting Officer & Principal Financial Officer (Age 60)
- Mr. Brian Jackman, Director of Marketing
How do I buy shares of Encision?
Shares of ECIA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Encision's stock price today?
One share of ECIA stock can currently be purchased for approximately $0.3550.
How big of a company is Encision?
What is Encision's official website?
How can I contact Encision?
Encision's mailing address is 6797 WINCHESTER CIRCLE, BOULDER CO, 80301. The medical device company can be reached via phone at 303-444-2600.
MarketBeat Community Rating for Encision (OTCMKTS ECIA)
MarketBeat's community ratings are surveys of what our community members think about Encision and other stocks. Vote "Outperform" if you believe ECIA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ECIA will underperform the S&P 500 over the long term. You may vote once every thirty days.
